Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_assertion type Assertion NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_head.
- NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_assertion description "[Defects in rat sarcoma viral oncogene homolog (RAS)-extracellular signal regulated kinase (ERK) and phosphatidylinositol 3-kinase (PI3K)-mammalian target of rapamycin (MTOR) signaling pathways have recently been shown to cause several genetic disorders classified as neuro-cardio-facial-cutaneous (NCFC) and Hamartoma syndromes.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_provenance.
- NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_assertion evidence source_evidence_literature NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_provenance.
- NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_assertion SIO_000772 18774199 NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_provenance.
- NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_assertion wasDerivedFrom befree-2016 NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_provenance.
- NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_assertion wasGeneratedBy ECO_0000203 NP691703.RABGL74MSNiCC3436ZjHe1FTGQUvUyYas0J0UUSw_2lqg130_provenance.